INTEGRATED BIOBANK OF LUXEMBOURG
YOUR EUROPEAN BIOSERVICE PROVIDER
codex4smes@ibbl.lu
INTEGRATED BIOBANK OF LUXEMBOURG YOUR EUROPEAN BIOSERVICE PROVIDER - - PowerPoint PPT Presentation
INTEGRATED BIOBANK OF LUXEMBOURG YOUR EUROPEAN BIOSERVICE PROVIDER codex4smes@ibbl.lu About IB IBBL A not-for-profit public institute, dedicated to supporting biomedical research for the benefit of patients, integrated within the Luxembourg
YOUR EUROPEAN BIOSERVICE PROVIDER
codex4smes@ibbl.lu
A not-for-profit public institute, dedicated to supporting biomedical research for the benefit of patients, integrated within the Luxembourg Institute of Health (LIH). IBBL’s strategy is to ▪ Support Luxembourg research ▪ Promote biobanking and infrastructure services to medical science research internationally
Founded in 2008 Move in 2017
codex4smes@ibbl.lu
can be long, expensive and risky
robustness and effectiveness
✓ improve the value of your biomarker discovery ✓ assess objectively and accurately biomarker robustness and its analytical characteristics for a quicker and smoother clinical translation ✓ increase the chances to secure an investment through an overall de- risking process for investors
codex4smes@ibbl.lu
codex4smes@ibbl.lu
✓ With a successful validation, IBBL helps you bring the biomarker to market ✓ If the validation is not successful, it helps you refocus your resources
codex4smes@ibbl.lu
IBBL service
Early Discovery
Biology Verified Patient Samples
Translate Discovery
Clinical Measure Established
Pre-Analytical Validation
Analyte-, Reagents-, Technology- Robust
Analytical Validation
Assay Performance, Fit-for-purpose
Biomarker Clinical Verification Biomarker Clinical Validation
Assessment and reporting of the robustness of your biomarker to common pre-analytical variables such as sample processing delays, storage and processing temperatures and freeze- thaw cycles
Assessment and reporting of the analytical characteristics of your biomarker assay including, precision, matrix effect, analytical range, specificity, sensitivity and stability
Pilot study of a limited sample size to verify the performance of your biomarker in clinical sample sets
codex4smes@ibbl.lu
codex4smes@ibbl.lu
Innovative Companion diagnostics candidate SMEs Regions
regional partner
form by December 14th 2018
Lead partner organisation
Expert Group Lead BioBank Support BioBank
Codex4SMEs Jury
input
transmitted to the biobanks and experts
criteria indicated in the guidelines
listed participants
codex4smes@ibbl.lu
Recommendation
Steering Committee (representatives of all partners)
codex4smes@ibbl.lu
codex4smes@ibbl.lu
www.ibbl.lu codex4smes@ibbl.lu